Why Do So Many People Quit Ozempic? The Real Reasons (2026)

Most people who start Ozempic do not stay on it. Real-world claims-data studies of people who begin a weight-loss-indicated GLP-1 like semaglutide consistently find that a large share stop within the first year — published cohorts and pharmacy-benefit analyses have reported figures ranging from roughly half to about two-thirds discontinuing within ~12 months.^[1][2] That is dramatically higher than the near-complete retention seen inside tightly supervised clinical trials, and it is the gap this article explains. The reasons cluster into six honest, well-documented drivers: gastrointestinal side effects (the number-one reason), cost and losing insurance coverage, feeling the drug plateaued or stopped working, reaching a goal weight and stopping, fear of weight regain or cosmetic and quality-of-life concerns, and access or supply frustrations. The catch is that stopping usually has a consequence: the STEP-1 trial extension showed people regained about two-thirds of their lost weight within a year of stopping.^[3] So for many people the smarter move than quitting outright is to address the actual driver — manage the side effect, switch to a cheaper option, or build a maintenance plan — with a prescriber. Ozempic is semaglutide; see our Ozempic drug page and Ozempic side effects guide. This is general educational information, not medical advice — do not start or stop on your own.

How many people actually quit Ozempic?

The headline is uncomfortable for a drug this effective: most people who start do not stay on it for long. Inside the pivotal trials, where patients get free medication, structured titration, and frequent check-ins, retention is high. In the real world it is not. A Prime Therapeutics / pharmacy-benefit analysis of people initiating high-potency, weight-loss-indicated GLP-1 receptor agonists found that 1-year persistence was low — a large fraction had stopped or had poor adherence by the end of the first year.^[1] A separate JAMA Network Open cohort of US adults with overweight or obesity treated with semaglutide or tirzepatide found high discontinuation within the first year, with a meaningful number later reinitiating — meaning "quitting" is often not permanent, but a stop-start pattern.^[2]

Across these real-world datasets, the commonly cited range is that roughly half to two-thirds of people discontinue within about a year.^[1][2] The exact percentage depends on the population, the specific drug, and how each study defines "discontinuation" (a gap in fills versus a documented stop), so it is best read as a range rather than a single number. The point that survives all the methodological caveats is the same: real-world quit rates are high, and understanding why is the first step to deciding whether quitting is actually your best move.

Reason 1: Gastrointestinal side effects (the #1 driver)

The single most common reason people quit Ozempic is gastrointestinal side effects — nausea, vomiting, diarrhea, and constipation. These are the most frequently reported adverse reactions in the Ozempic prescribing information, listed in the §6 Adverse Reactions section, and they tend to be worst during the early weeks and the days after each dose increase.^[4] For most people the nausea is mild-to-moderate and fades as the body adapts. For a minority it does not — and when nausea or vomiting is severe enough to interfere with eating, working, or daily life, people stop.

This is not just a statistic. Several public figures have spoken about quitting for exactly this reason. Comedian Amy Schumer has publicly said she stopped taking Ozempic because the side effects left her bedridden and unable to function — an account she has shared herself in interviews and on social media.^[4] Presented as her own reported experience rather than a medical claim, it illustrates the real top reason: for some people the GI burden is genuinely debilitating, and no amount of weight loss feels worth being sick. The constructive nuance is that severe GI effects are often addressable — slower titration, holding a dose longer before stepping up, dietary changes, and prescriber-directed anti-nausea strategies resolve it for many people before they have to quit entirely. See our full Ozempic side effects guide.

Reason 2: Cost and losing insurance coverage

The second great driver of quitting is money. The list price of brand-name Ozempic and the weight-management GLP-1s runs roughly $1,000 or more per month at retail without insurance. Many people start while covered by insurance or a manufacturer copay card, then face a cliff: a plan drops weight-loss GLP-1 coverage, a prior authorization lapses, a new job changes the formulary, or a copay card maxes out. Paying $1,000-plus per month out of pocket is simply not sustainable for most households, and when the bill arrives, people stop — not because the drug failed, but because they cannot afford it.^[1]

This is the reason most worth pausing on, because it is the one with the clearest alternative to quitting. If cost is why you would stop, you usually do not have to stop the medication class — you can switch to a cheaper legitimate channel. Cash-pay GLP-1 pricing changed dramatically in late 2025 and 2026: manufacturer direct-to-patient channels and vetted compounded-semaglutide providers brought the floor far below the $1,000+ retail wall. Our cheapest GLP-1 without insurance buyer's guide walks every tier. Quitting because of cost, when a cheaper version of the same medicine exists, often means trading away your results to solve a problem that switching could solve instead.

Reason 3: A plateau or "it stopped working"

A third common reason is the feeling that the drug has plateaued or stopped working. Weight loss on Ozempic is fastest early and then slows; eventually it levels off as the body reaches a new set point. To someone watching the scale, a normal, expected plateau can read as failure — "it's not doing anything anymore" — and that perception drives people to quit. In reality a plateau is usually the medication holding a lower weight rather than failing; stopping at that point typically reverses the loss rather than locking it in. Sometimes a genuine slowdown reflects being under-dosed, and the answer is a prescriber-directed dose adjustment, not quitting. The plateau feeling is real, but it is one of the reasons where stopping most often backfires.

Reason 4: Reaching a goal weight (then often regaining)

Some people quit for a happy reason: they reached their goal weight and assumed the job was done. This is intuitive — you take an antibiotic until the infection clears, so why not stop the weight-loss drug once you have lost the weight? The problem is that obesity behaves like a chronic, relapsing condition, not an acute one. Ozempic manages weight while you take it; it does not permanently reset the body's regulation of appetite and weight. When people stop after hitting a goal, the appetite suppression lifts and the biology that drove the original weight gain reasserts itself. The result is usually regain — which leads directly to the next reason.

Reason 5: Fear of weight regain, Ozempic face, and muscle loss

A fifth cluster of reasons is about the downsides of the weight loss itself and the fear surrounding stopping. Rapid weight loss can produce facial volume loss — popularly called "Ozempic face" — and a portion of the weight lost on any GLP-1 is lean muscle mass rather than fat, which concerns people focused on strength, metabolism, and long-term health. Some people quit over these cosmetic and body-composition worries. Others quit, paradoxically, out of fear of weight regain combined with not wanting to be on a medication indefinitely — they would rather stop on their own terms than feel dependent. The honest counterpoint is that muscle loss is partly manageable with adequate protein and resistance training while on the drug (see our muscle loss guide), and that quitting to avoid regain usually causes the very regain people fear.

Reason 6: Access and supply frustrations

The sixth driver is logistical: access and supply. Over the GLP-1 boom, intermittent shortages, pharmacy back-orders, prior-authorization delays, and the hassle of refills and cold-chain shipping pushed people to lapse. A missed refill becomes a two-week gap, the gap becomes a month, and a logistical interruption quietly becomes a permanent discontinuation. This kind of "accidental quitting" is common and frustrating because it has nothing to do with whether the drug worked — and it is one of the more solvable reasons, since a reliable prescriber and pharmacy channel, or switching products, can remove the friction.

The reasons people quit — and what you can do instead

Here is each common reason for quitting Ozempic alongside the constructive alternative. All management is prescriber-directed — do not change or stop your medication on your own.

What actually happens when you quit

The most important thing to understand before quitting is the consequence. In the STEP-1 trial extension, participants who stopped semaglutide (and stopped the lifestyle support) regained about two-thirds of the weight they had lost within a year, and the cardiometabolic improvements — blood pressure, lipids, blood sugar markers — largely reversed alongside the weight.^[3] This is not a willpower failure; it is the expected biology of stopping a medication that was actively suppressing appetite. Our dedicated guide to weight regain after stopping covers the evidence in full.

That is why "quitting" deserves a second look. For a real medical reason — intolerable side effects that cannot be managed, pregnancy, a new contraindication — stopping under prescriber guidance is the right call. But when the reason is cost, a plateau, hitting a goal, or supply hassle, the better move is usually not to quit but to fix the driver: manage the side effect, switch to a cheaper legitimate option, or build a maintenance/step-down plan with your clinician. If you are choosing where to continue under proper supervision, compare the best semaglutide providers. The decision to start or stop is a medical one — do not do either on your own.